Delivery Order SPE2DB20D7059-SPE2DB24FPVY1
Award Date
12/15/23
Potential Completion Date
12/18/23
Potential Value
$9.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.58 firm fixed-price delivery order is for the ROTATEQ vaccine, a vaccine for the prevention of rotavirus gastroenteritis in children. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTATEQ VACCINE 2ML product. The $2,474.49 order is part of Amerisourcebergen's broader indefinite delivery contract with DLA, valued up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. This delivery order...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $15,765.90 contract is for the supply of the ROTATEQ vaccine, a 2 ml dosage form, with a performance period through March 13, 2024. This delivery order is issued under a single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to...
The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTATEQ VACCINE 2ML. The $17,070.82 order has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, which has a potential value of up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,576.59 contract is for the delivery of ROTATEQ vaccine 2ML to support military treatment programs and facilities. The order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ROTATEQ vaccine, a rotavirus vaccine, with a ceiling value of $10,549.02. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the ROTATEQ vaccine. The $1,576.59 delivery order has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,370.61, is for the supply of the ROTATEQ vaccine in 2-milliliter doses. It is a firm-fixed-price, non-set-aside contract with a completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,148.00 firm fixed-price delivery order is for the supply of the ROTATEQ vaccine, a rotavirus vaccine, to support military healthcare programs. The contract has an ultimate completion date of March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,259.71 firm fixed-price contract is for the supply of ROTATEQ VACCINE 2ML, with a performance period through May 22, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...